Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
European Paediatric Soft Tissue Sarcoma Study Group protocol for Localized Non-Rhabdomyosarcoma Soft Tissue Sarcomas 2005
2005-001139-31Phase 3Completed
- Sponsor
- University Hospitals of Leicester NHS Trust
- Start
- Jan 2006
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of doxorubicin and ifosfamide in non-rhabdomyosarcoma soft tissue sarcoma (NRSTS), sponsored by University Hospitals of Leicester NHS Trust. Primary endpoints: Uniformity of treatment across European NRSTS centres and Clinical outcomes under standardized protocol. Started Jan 2006; status: completed.
02
Drugs
doxorubicinifosfamide
03
Conditions
non-rhabdomyosarcoma soft tissue sarcoma (NRSTS)
Beyond the preview
Go deeper on 2005-001139-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-001139-31.